Physician profile
Prashanth Jayaraj
NPI 1437785474
$1,403.24
in general payments reported to CMS, 2019-2025
14 companies · $13.72 in 2025
The $13.72 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.67 · 2022: $403 · 2023: $708 · 2024: $247 · 2025: $13.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $968.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $333.60 | 2022-2024 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $233.15 | 2023 | Austedo Xr, Austedo |
| Acadia Pharmaceuticals INC | $222.84 | 2022 | |
| Averitas Pharma INC. | $150.35 | 2023 | Qutenza |
| Abbvie INC. | $125.00 | 2023 | |
| Viiv Healthcare Company | $123.71 | 2023 | Dovato |
| Novo Nordisk INC | $78.41 | 2024 | Wegovy |
| Amneal Pharmaceuticals LLC | $31.67 | 2021 | |
| Merck Sharp & Dohme LLC | $19.81 | 2023 | Delstrigo, Pifeltro |
| Exact Sciences Corporation | $19.76 | 2023 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $19.35 | 2023 | |
| Amgen INC. | $16.72 | 2023 | Evenity, Prolia |
| Organon LLC | $15.15 | 2024 | |
| Kestra Medical Technology Services, INC. | $13.72 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prashanth Jayaraj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.